- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Spasticity, Multiple Sclerosis, Stroke, Trauma in New Zealand
Total 530 results
-
University of California, Los AngelesJohns Hopkins University; University of Colorado, Denver; Mayo Clinic; University... and other collaboratorsCompletedRelapsing Remitting Multiple SclerosisUnited States, Canada
-
Atara BiotherapeuticsTerminatedPrimary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States, Australia, Canada
-
Providence Health & ServicesGenentech, Inc.CompletedRelapsing Remitting Multiple SclerosisUnited States
-
Acorda TherapeuticsPRA Health SciencesCompletedMultiple Sclerosis, Acute RelapsingUnited States
-
BiogenTerminatedRelapsing-Remitting Multiple SclerosisCanada
-
BiogenBiogen Idec A/SCompletedExerciseSweden, Finland, New Zealand, Denmark, Norway, Australia
-
BiogenTerminatedMultiple Sclerosis, Relapsing-Remitting | Relapsing-Remitting Multiple SclerosisCanada
-
State University of New York at BuffaloGenentech, Inc.Active, not recruitingPrimary Progressive Multiple SclerosisUnited States
-
State University of New York at BuffaloGenentech, Inc.Active, not recruitingPrimary Progressive Multiple SclerosisUnited States
-
BiogenCompletedRelapsing-Remitting Multiple SclerosisUnited States, Croatia, Bulgaria, Czech Republic, France, Mexico, Poland, Spain, Germany, Belarus, Estonia, Latvia, Romania, Ukraine, Israel, New Zealand, Slovakia, Greece, India, Serbia, Ireland, Costa Rica, Canada, Belgium, Macedonia,... and more
-
US Department of Veterans AffairsCompletedStroke | Multiple Sclerosis | Spinal Cord InjuriesUnited States
-
BiogenCompletedRelapsing-Remitting Multiple SclerosisUnited States, France, Germany, Spain, Belgium, Czechia, Switzerland, United Kingdom, Austria, New Zealand, Australia, South Africa, Ukraine, Italy, Slovakia, Greece, Poland, Israel, Netherlands, Bulgaria, Serbia, India, Romania, Estonia and more
-
GlaxoSmithKlineCompletedMultiple SclerosisItaly, Germany, Spain, United Kingdom, Australia, Netherlands, New Zealand, Russian Federation, France, Canada, Austria, Poland, Finland, Norway
-
Novartis PharmaceuticalsCompletedMayzent (Siponimod) Onboarding of Secondary Progressive Multiple Sclerosis (SPMS) Patients With MSGoSecondary Progressive Multiple SclerosisAustralia
-
Merz Pharmaceuticals GmbHCompletedPost-stroke Spasticity of the Upper LimbPoland, United States, Czech Republic, Germany, Hungary, India, Russian Federation
-
Opexa Therapeutics, Inc.CompletedRelapsing-Remitting Multiple SclerosisUnited States
-
Merz Pharmaceuticals GmbHCompletedPost-stroke Spasticity of the Lower LimbGermany, Poland, Spain, United States, Czech Republic, Russian Federation, Canada, France, Italy
-
Johns Hopkins UniversityUniversity of Pennsylvania; Washington University School of Medicine; Yale University and other collaboratorsCompletedRelapsing Remitting Multiple SclerosisUnited States
-
Artielle ImmunoTherapeuticsUnknownMultiple Sclerosis, Chronic Progressive | Multiple Sclerosis, Relapsing-RemittingUnited States
-
Genzyme, a Sanofi CompanyTerminatedRelapsing-remitting Multiple SclerosisRussian Federation, United States, Canada, Poland
-
BiogenTerminatedRelapsing-Remitting Multiple SclerosisUnited States, Spain, Germany, Australia, Sweden, Czechia, France, Italy, United Kingdom
-
Anokion SAActive, not recruitingRelapsing Remitting Multiple Sclerosis | Multiple Sclerosis (MS)United States
-
Eli Lilly and CompanyCompletedRelapsing-Remitting Multiple SclerosisHungary, United States, France, Ukraine, Poland, Germany, Israel, Russian Federation, Czechia, Serbia, Romania, Slovakia, Bulgaria
-
Novartis PharmaceuticalsRecruitingRelapsing-Remitting Multiple SclerosisUnited States, Canada
-
NYU Langone HealthCompletedPediatric Multiple SclerosisUnited States
-
Kessler FoundationCompletedMultiple Sclerosis | Traumatic Brain InjuryUnited States
-
Genzyme, a Sanofi CompanyTerminatedRelapsing-remitting Multiple SclerosisSweden, Poland, Russian Federation, United States, Canada
-
Hoffmann-La RochePPDRecruitingRelapsing-Remitting Multiple SclerosisUnited States, Belgium, Canada, Spain, India, Italy, Mexico, Portugal, Argentina, Austria, Brazil, United Kingdom, Germany, Netherlands, Serbia, Australia, Bulgaria, France, Greece, Hungary, Poland, Ukraine, Estonia, Denmark, Croatia, Latvia and more
-
Teva Branded Pharmaceutical Products R&D, Inc.CompletedRelapsing-Remitting Multiple SclerosisUnited States
-
City University of New YorkRecruitingMultiple Sclerosis,Gait, ExerciseUnited States
-
Transparency Life SciencesUnknownMultiple Sclerosis, Relapsing-RemittingUnited States
-
BiogenAbbVieCompletedRelapsing-Remitting Multiple SclerosisSweden, United States, Brazil, Czech Republic, Italy, Russian Federation, Spain, United Kingdom, Germany, Ukraine, Denmark, Finland, Romania, Canada, France, Hungary, Israel, Switzerland, Serbia, India, Mexico, Poland, Georgia, Ireland, Argentin... and more
-
Novartis PharmaceuticalsTerminatedRelapsing-remitting Multiple Sclerosis (RRMS)United States, Canada, Mexico, Brazil, Puerto Rico, Argentina, Chile
-
Fred LublinNational Institute of Neurological Disorders and Stroke (NINDS)CompletedRelapsing Remitting Multiple SclerosisUnited States, Canada
-
Kessler FoundationSt. Barnabas Medical CenterRecruitingMultiple Sclerosis, Relapsing-RemittingUnited States
-
TG Therapeutics, Inc.CompletedRelapsing Multiple Sclerosis (RMS)United States
-
MedDay Pharmaceuticals SATerminatedMultiple SclerosisUnited States, Spain, Canada, Australia, United Kingdom, Belgium, Turkey, Czechia, Poland, Italy, Hungary, Germany, Sweden
-
BiogenAlkermes, Inc.CompletedRelapsing Remitting Multiple SclerosisUnited States, Germany, Poland
-
Kessler FoundationHackensack Meridian HealthRecruitingMultiple Sclerosis, Relapsing-RemittingUnited States
-
Contineum TherapeuticsRecruitingRelapsing Remitting Multiple SclerosisUnited States
-
NovartisCompletedMultiple SclerosisUnited States, Turkey, Romania, United Kingdom, Poland, Austria, Canada, Australia
-
National Institute of Allergy and Infectious Diseases...Novartis Pharmaceuticals; Autoimmunity Centers of ExcellenceCompletedSecondary Progressive Multiple SclerosisUnited States
-
IMS HEALTH GmbH & Co. OHGEMD SeronoCompletedRelapsing-remitting Multiple SclerosisUnited States, Canada
-
Clene NanomedicineGeorge ClinicalCompletedRelapsing Multiple SclerosisAustralia
-
MediciNovaNational Institute of Neurological Disorders and Stroke (NINDS); National Institutes... and other collaboratorsCompletedSafety, Tolerability and Activity Study of Ibudilast in Subjects With Progressive Multiple SclerosisMultiple Sclerosis, Secondary Progressive | Multiple Sclerosis, Primary ProgressiveUnited States
-
BiogenAbbVieTerminatedMultiple Sclerosis | Relapsing-Remitting Multiple SclerosisUnited States, Denmark, Italy, United Kingdom, Czechia, Canada, Hungary, Spain, Australia, Israel, Georgia, Serbia, Russian Federation, Ukraine, India, Poland, Brazil, France, Argentina, Germany, Greece, Ireland, Mexico, Moldova, Republic... and more
-
Novartis PharmaceuticalsCompletedRelapsing Remitting Multiple SclerosisUnited States, Puerto Rico
-
Universitätsklinikum KölnRecruiting
-
BiogenCompleted
-
EMD SeronoPfizerCompletedRelapsing-remitting Multiple SclerosisUnited States, United Kingdom, Argentina, Austria, Brazil, France, Germany, Italy, Netherlands, Russian Federation, Spain, Switzerland